论文部分内容阅读
目的探究氯吡格雷与阿司匹林共同治疗老年冠心病的价值。方法特选取2015年2月~2017年1月,我院收治的冠心病患者60例,作为此次研究对象,按照医学分组中常用的随机数字表法将其分成观察组和对照组,每组各30例,对照组患者给予阿司匹林进行治疗,观察组则在对照组的基础上加用氯吡格雷。对比两组患者的临床治疗效果。结果 (1)治疗有效率:观察组患者的治疗有效率为93%,明显高于对照组的73%,组间对比差异显著(P<0.05);(2)在接受治疗后,观察组患者在左室射血分数(LVEF)、左室收缩末期内径(LVESD)、左室舒张末期内径(LVEDD)等指标的改善情况上,明显优于对照组,组间对比差异显著(P<0.05)。结论将阿司匹林与氯吡格雷联合,应用于老年冠心病患者的临床治疗中,可有效的提高患者的临床治疗效果,改善患者的心功能指标,同时也具有较好的用药安全性特点,因此,值得在临床实践中进行大范围的推广和使用。
Objective To investigate the value of co-treatment of geriatric coronary heart disease with clopidogrel and aspirin. Methods From February 2015 to January 2017, 60 patients with coronary heart disease admitted from our hospital were divided into observation group and control group according to the random number table method commonly used in medical grouping, and each group The patients in the control group were given aspirin for treatment. The observation group was given clopidogrel on the basis of the control group. The clinical effects of two groups were compared. Results (1) Therapeutic efficiency: The effective rate of treatment in the observation group was 93%, which was significantly higher than that in the control group (73%) (P <0.05). (2) After treatment, Compared with control group, LVEF, LVESD, LVEDD and other indexes were significantly improved (P <0.05) . Conclusion Aspirin and clopidogrel combined with clinical treatment of elderly patients with coronary heart disease can effectively improve the clinical efficacy of patients and improve patients with cardiac function, but also has good drug safety features, therefore, It is worth in the clinical practice of a wide range of promotion and use.